Dharambir Kashyap

4.1k total citations · 2 hit papers
48 papers, 2.7k citations indexed

About

Dharambir Kashyap is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Dharambir Kashyap has authored 48 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Pharmacology and 8 papers in Oncology. Recurrent topics in Dharambir Kashyap's work include Natural product bioactivities and synthesis (6 papers), Free Radicals and Antioxidants (4 papers) and Natural Antidiabetic Agents Studies (4 papers). Dharambir Kashyap is often cited by papers focused on Natural product bioactivities and synthesis (6 papers), Free Radicals and Antioxidants (4 papers) and Natural Antidiabetic Agents Studies (4 papers). Dharambir Kashyap collaborates with scholars based in India, United States and Canada. Dharambir Kashyap's co-authors include Hardeep Singh Tuli, Anil Kumar Sharma, Katrin Sak, Vivek Kumar Garg, Ajay Sharma, Sardul Singh Sandhu, Neelam Goel, Anupam Bishayee, Mükerrem Betül Yerer and Sandeep Punia and has published in prestigious journals such as International Journal of Molecular Sciences, CHEST Journal and Life Sciences.

In The Last Decade

Dharambir Kashyap

43 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural product-based nanoformulations for cancer therapy: Opportunities and challenges

2019 314 citations Dharambir Kashyap, Hardeep Singh Tuli et al. profile →
Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis

2021 252 citations Dharambir Kashyap, Vivek Kumar Garg et al. Advances in protein chemistry and structural biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dharambir Kashyap India	23	1.5k	451	373	332	314	48	2.7k
Ghulam Jilany Khan China	24	1.2k 0.8×	283 0.6×	455 1.2×	327 1.0×	295 0.9×	76	2.8k
Kuang‐Chi Lai Taiwan	33	1.5k 1.0×	393 0.9×	507 1.4×	194 0.6×	378 1.2×	70	2.8k
Chia‐Jui Weng Taiwan	26	1.0k 0.7×	384 0.9×	287 0.8×	248 0.7×	274 0.9×	36	2.1k
Dong‐Oh Moon South Korea	37	1.8k 1.2×	751 1.7×	353 0.9×	299 0.9×	395 1.3×	87	3.8k
Sang Hoon Jung South Korea	29	1.4k 0.9×	285 0.6×	533 1.4×	273 0.8×	252 0.8×	83	2.7k
Zheng‐Yuan Su Taiwan	29	2.0k 1.4×	247 0.5×	308 0.8×	440 1.3×	279 0.9×	54	2.9k
Yen‐Chou Chen Taiwan	32	2.0k 1.4×	677 1.5×	520 1.4×	414 1.2×	335 1.1×	83	3.6k
Devivasha Bordoloi India	30	1.9k 1.3×	621 1.4×	310 0.8×	180 0.5×	410 1.3×	50	3.7k
Jo‐Hua Chiang Taiwan	31	1.3k 0.9×	316 0.7×	321 0.9×	146 0.4×	337 1.1×	56	2.3k
Saleh A. Almatroodi Saudi Arabia	29	874 0.6×	303 0.7×	327 0.9×	315 0.9×	227 0.7×	75	2.4k

Countries citing papers authored by Dharambir Kashyap

Since Specialization

Citations

This map shows the geographic impact of Dharambir Kashyap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharambir Kashyap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharambir Kashyap more than expected).

Fields of papers citing papers by Dharambir Kashyap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dharambir Kashyap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharambir Kashyap. The network helps show where Dharambir Kashyap may publish in the future.

Co-authorship network of co-authors of Dharambir Kashyap

This figure shows the co-authorship network connecting the top 25 collaborators of Dharambir Kashyap. A scholar is included among the top collaborators of Dharambir Kashyap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dharambir Kashyap. Dharambir Kashyap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Singh, Pankaj, Dharambir Kashyap, Joseph Jillwin, et al.. (2025). PROTAC-Based Antivirals for Respiratory Viruses: A Novel Approach for Targeted Therapy and Vaccine Development. Microorganisms. 13(7). 1557–1557.

Kashyap, Dharambir, et al.. (2024). Targeting Interleukin-13 Receptor α2 and EphA2 in Aggressive Breast Cancer Subtypes with Special References to Chimeric Antigen Receptor T-Cell Therapy. International Journal of Molecular Sciences. 25(7). 3780–3780. 2 indexed citations

Chatterjee, Debajyoti, et al.. (2024). Primary Rosai‐Dorfman disease of the central nervous system: A clinical, histological, and molecular appraisal. Neuropathology. 44(5). 366–375.

Pal, Deeksha, Dharambir Kashyap, Aman Sharma, et al.. (2024). Withaferin A: the potent anti-cancer agent from Ashwagandha. 36(3). 2 indexed citations

Kashyap, Dharambir, et al.. (2024). Cancer associated fibroblasts modulate the cytotoxicity of anti-cancer drugs in breast cancer: An in vitro study. Breast Disease. 43(1). 25–36. 2 indexed citations

Kashyap, Dharambir, et al.. (2023). Heterogeneity of the Tumor Microenvironment Across Molecular Subtypes of Breast Cancer. Applied immunohistochemistry & molecular morphology. 31(8). 533–543. 8 indexed citations

Kashyap, Dharambir, Riya Sharma, Neelam Goel, et al.. (2023). Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance. Frontiers in Genetics. 13. 993687–993687. 9 indexed citations

Kashyap, Dharambir, et al.. (2021). Oncogenic and Tumor Suppressive Components of the Cell Cycle in Breast Cancer Progression and Prognosis. Pharmaceutics. 13(4). 569–569. 37 indexed citations

Sharma, Neha, et al.. (2021). Biochemical and histopathological evaluation of an in vivo model of breast cancer. GSC Biological and Pharmaceutical Sciences. 16(1). 202–210. 4 indexed citations

10.

Sreedharanunni, Sreejesh, Man Updesh Singh Sachdeva, Dharambir Kashyap, et al.. (2021). The relative expression levels of CD148 and CD180 on clonal B cells and CD148/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltrating blood and bone marrow – Results from a single centre pilot study. International Journal of Laboratory Hematology. 43(5). 1123–1131. 5 indexed citations

11.

Kashyap, Dharambir, Vivek Kumar Garg, & Neelam Goel. (2021). Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis. Advances in protein chemistry and structural biology. 125. 73–120. 252 indexed citations breakdown →

12.

Kashyap, Dharambir, et al.. (2021). Detection of c.755T>C; p.L265P/c.751C>T;p.264R/* compound heterozygous MYD88 mutation in a case of Waldenstrom macroglobulinemia. Indian Journal of Hematology and Blood Transfusion. 37(4). 702–704.

13.

Mitra, Suvradeep, et al.. (2020). Tumour angiogenesis and c‐Met pathway activation – implications in breast cancer. Apmis. 128(4). 316–325. 14 indexed citations

14.

Kashyap, Dharambir & Hardeep Singh Tuli. (2018). Flavonoids in Triple Negative Breast Cancer: Chemopreventive Phytonutrients. 6(1). 4 indexed citations

15.

Kashyap, Dharambir, Ajay Sharma, Hardeep Singh Tuli, et al.. (2018). Molecular targets of celastrol in cancer: Recent trends and advancements. Critical Reviews in Oncology/Hematology. 128. 70–81. 112 indexed citations

16.

Kashyap, Dharambir, Hardeep Singh Tuli, Vivek Kumar Garg, Neelam Goel, & Anupam Bishayee. (2018). Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential. Molecular Diagnosis & Therapy. 22(2). 179–201. 33 indexed citations

17.

Kashyap, Dharambir, Ajay Sharma, Katrin Sak, et al.. (2017). Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy. Life Sciences. 194. 75–87. 120 indexed citations

18.

Kashyap, Dharambir, Gaurav Kumar, Ajay Sharma, et al.. (2016). Mechanistic insight into carnosol-mediated pharmacological effects: Recent trends and advancements. Life Sciences. 169. 27–36. 49 indexed citations

19.

Kashyap, Dharambir, Hardeep Singh Tuli, & Anil Kumar Sharma. (2016). Ursolic acid (UA): A metabolite with promising therapeutic potential. Life Sciences. 146. 201–213. 251 indexed citations

20.

Tuli, Hardeep Singh, Dharambir Kashyap, Anil Kumar Sharma, & Sardul Singh Sandhu. (2015). Molecular aspects of melatonin (MLT)-mediated therapeutic effects. Life Sciences. 135. 147–157. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact